| Overview |
| bsm-61317r-100ul |
| Complement C4 / C4a Monoclonal Antibody |
| WB, FCM, IHC-P, IHC-F, IF |
| Human |
| Specifications |
| Unconjugated |
| Rabbit |
| KLH conjugated synthetic peptide derived from human Complement C4 A |
| Monoclonal |
| Recombinant |
| IgG |
| 1ug/ul |
| Purified by Protein A. |
| 10mM phosphate buffered saline(pH 7.4) with 150mM sodium chloride, 0.05% BSA, 0.02% sodium azide and 50% glycerol. |
| Shipped at 4°. Store at -20°C for one year. Avoid repeated freeze/thaw cycles. |
| Target |
| 720 |
| P0C0L4 |
| Secreted |
| Acidic C4; Acidic complement C4; Basic C4; Basic complement C4; C4A; C4A2; C4A3; C4A4; C4A6; C4AD; C4B1; C4B12; C4B2; C4B3; C4BD; C4F; C4S; CPAMD2; CPAMD3. |
| Non-enzymatic component of C3 and C5 convertases and thus essential for the propagation of the classical complement pathway. Covalently binds to immunoglobulins and immune complexes and enhances the solubilization of immune aggregates and the clearance of IC through CR1 on erythrocytes. |
| Application Dilution |
| WB |
:1:1000-1:2000 |
| FCM |
FCM:1:20-1:100 |
| IHC-P |
IHC-P:1:100-1:200 |
| IHC-F |
IHC-F:1:100-1:200 |
| IF |
IF:1:100-1:200 |
Powered by Bioz